Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.250
-0.070 (-3.02%)
Apr 29, 2026, 2:18 PM EDT - Market open
Galectin Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 17.72 | 15.12 | 25.66 | 18.59 | 39.65 | Upgrade
|
| Cash & Short-Term Investments | 17.72 | 15.12 | 25.66 | 18.59 | 39.65 | Upgrade
|
| Cash Growth | 17.20% | -41.08% | 38.02% | -53.11% | 46.08% | Upgrade
|
| Prepaid Expenses | 1.71 | 2.13 | 2.04 | 1.95 | 2.17 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 19.44 | 17.25 | 27.71 | 20.55 | 41.82 | Upgrade
|
| Property, Plant & Equipment | 0.02 | - | 0.05 | 0.09 | - | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.24 | 0.44 | 0.65 | 0.01 | Upgrade
|
| Total Assets | 19.53 | 17.5 | 28.2 | 21.29 | 41.83 | Upgrade
|
| Accounts Payable | 3.25 | 5.66 | 6.43 | 3.89 | 1.81 | Upgrade
|
| Accrued Expenses | 4.7 | 8.19 | 9.14 | 9.02 | 7.16 | Upgrade
|
| Current Portion of Long-Term Debt | - | 21.49 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.02 | 0.02 | 0.05 | 0.04 | 0.01 | Upgrade
|
| Other Current Liabilities | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | Upgrade
|
| Total Current Liabilities | 8.03 | 35.41 | 15.68 | 13.01 | 9.03 | Upgrade
|
| Long-Term Debt | 137.7 | 85.16 | 71.74 | 39.83 | 29.05 | Upgrade
|
| Long-Term Leases | - | - | 0.02 | 0.07 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1 | 0.57 | 1.13 | Upgrade
|
| Total Liabilities | 145.73 | 120.57 | 88.44 | 53.48 | 39.21 | Upgrade
|
| Common Stock | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 304.07 | 296.22 | 291.85 | 275.08 | 271 | Upgrade
|
| Retained Earnings | -432.55 | -401.57 | -354.37 | -309.57 | -270.69 | Upgrade
|
| Total Common Equity | -128.41 | -105.29 | -62.46 | -34.43 | 0.37 | Upgrade
|
| Shareholders' Equity | -126.2 | -103.07 | -60.24 | -32.19 | 2.62 | Upgrade
|
| Total Liabilities & Equity | 19.53 | 17.5 | 28.2 | 21.29 | 41.83 | Upgrade
|
| Total Debt | 137.72 | 106.66 | 71.81 | 39.93 | 29.06 | Upgrade
|
| Net Cash (Debt) | -120 | -91.54 | -46.15 | -21.34 | 10.59 | Upgrade
|
| Net Cash Growth | - | - | - | - | -60.90% | Upgrade
|
| Net Cash Per Share | -1.88 | -1.47 | -0.77 | -0.36 | 0.18 | Upgrade
|
| Filing Date Shares Outstanding | 65.83 | 63.18 | 61.9 | 59.44 | 59.36 | Upgrade
|
| Total Common Shares Outstanding | 65.2 | 63.16 | 61.85 | 59.43 | 59.34 | Upgrade
|
| Working Capital | 11.41 | -18.16 | 12.03 | 7.54 | 32.79 | Upgrade
|
| Book Value Per Share | -1.97 | -1.67 | -1.01 | -0.58 | 0.01 | Upgrade
|
| Tangible Book Value | -128.41 | -105.29 | -62.46 | -34.43 | 0.37 | Upgrade
|
| Tangible Book Value Per Share | -1.97 | -1.67 | -1.01 | -0.58 | 0.01 | Upgrade
|
| Machinery | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Leasehold Improvements | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.